← Eichor
Study identifier: NCT07271771 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity

Condition: Osteoporosis  ·  Sponsor: Aarhus University Hospital

PhasePhase 4
Planned participants40
Who can joinFemale, 40 Years to no upper limit
Healthy volunteersNo

About this study

Randomized, placebo controlled prospective trial evaluating the effect of denosumab on insulin sensitivity and muscle strength.

This description comes directly from the study's public registry record.

Talk to the study team

Anne Sophie Sølling, MD, PhD  ·  +45 22 30 05 24  ·  annesoel@rm.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Aarhus University HospitalAarhus, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07271771